1．庄志雄，陈雯，林忠宁．靶器官毒理学．北京:化学工业出版社，2006．

2．王心如，周宗灿．毒理学基础．第4版．北京:人民卫生出版社，2006．

3．楼宜嘉．药物毒理学．北京:人民卫生出版社，2003．

4．谭毓治．药物毒理学．北京:科学出版社，2010．

5．张锦雀，黄丽英．肝损伤动物模型研究进展．福建医科大学学报，2009，43( 1) : 86-88．

6．Sahu SC．Hepatotoxicity from genomics to in vitro and in vivo models．Chichester: John Wiley＆Sons，Inc．，2007．

7．Klaassen CD．Casarett and Doull’s toxicology: the basic science of poisons．7th ed．New York: McGraw-Hill Companies，Inc．，2008．

8．Marrer E，Dieterle F．Impact of biomarker development on drug safety assessment．Toxicol Appl Pharmacol，2010，243( 2) : 167-179．

9．Ozer J，Ratner M，Shaw M，et al．The current state of serum biomarkers of hepatotoxicity．Toxicology，2008，245 ( 3) : 194-205．

10．Muller PY，Dieterle F．Tissue-specific，non-invasive toxicity biomarkers: translation from preclinical safety assessment to clinical safety monitoring．Expert Opin Drug Metab Toxicol，2009，5( 9) : 1023-1038．

11．Shi Q，Hong H，Senior J，et al．Biomarkers for drug-induced liver injury．Expert Rev Gastroenterol Hepatol，2010，4( 2) : 225-234．

12．Cortez MA，Calin GA．MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases．Expert Opin Biol Ther，2009，9( 6) : 703-711．

13．Saha B，Nandi D．Farnesyltransferase inhibitors reduce ras activation and ameliorate acetaminophen-induced liver injury in mice．Hepatology，2009，50( 5) : 1547-1557．

14．Berge RD，Sun J，Schnachkenberg LK．Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity．Toxicol Appl Pharmacol，2010，243( 2) : 154-166．

15．Lee MS，Jung BH，Chung BC，et al．Metabolomics study with gas chromatography-mass spectrometry for predicting valproic acid-induced hepatotoxicity and discovery of novel biomarkers in rat urine．Int J Toxicol，2009，28( 5) : 392-404．